Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login

Observational studies

Gout treatment does not raise CKD risk

Study shows serum urate levels can be lowered using allopuruinol in gout without risk to kidneys.

Coloured X-ray of the fingers of a patient with gout

Source: Jean-Denis Laredo, ISM / Science Photo Library

The researchers say their findings may help reassure doctors that serum urate levels can be lowered in gout using allopurinol without an increased risk to the kidneys

Gout and chronic kidney disease (CKD) commonly occur together but clinicians can be cautious about using urate-lowering therapy in such patients for fear it may worsen renal function.

Using UK general practice data, researchers compared 13,685 newly diagnosed gout patients who began taking allopurinol between 2000 and 2014 with an equal number of matched controls who had no allopurinol exposure.

The authors, who reported their results at the ACR/ARHP annual meeting in Washington on 14 November 2016[1], found that 1,384 and 1,372 patients in each group, respectively, developed CKD stage 3 or above during a mean follow-up of four years. Analysis showed no increased risk in the allopurinol group after adjusting for confounding factors.

The researchers say their findings should help reassure clinicians that serum urate levels can be lowered in gout using allopurinol without an increased risk to the kidneys.

Citation: Clinical Pharmacist DOI: 10.1211/CP.2016.20201989

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics

    Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.

    £37.00Buy now
  • Biological Therapeutics

    Biological Therapeutics

    An introduction to the treatment of disease using biological medicines derived from living plant and animal tissues.

    £32.00Buy now
  • FASTtrack: Pharmacology

    FASTtrack: Pharmacology

    FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.

    £24.00Buy now
  • Pharmacy Case Studies

    Pharmacy Case Studies

    Understand the application of therapeutics in clinical practice with Pharmacy Case Studies. This book helps you to demonstrate the knowledge gained during your studies.

    £32.00Buy now
  • Integrated Pharmacy Case Studies

    Integrated Pharmacy Case Studies

    Over 90 case studies based on real life patient-care scenarios. Each case includes learning outcomes and references.

    £42.00Buy now
  • Sampson's Textbook of Radiopharmacy

    Sampson's Textbook of Radiopharmacy

    This well-established textbook provides specialised information on the use of radiopharmaceuticals in the detection and treatment of diseases.

    £79.00Buy now

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Supplementary images

  • Coloured X-ray of the fingers of a patient with gout

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.